Kazia Therapeutics Ltd ADR
Quarterly Financials
| Values in thousands | 2023-12-31 | 2023-09-30 |
|---|---|---|
Revenue | $ | $ |
Gross Profit | ||
EBITDA | -7,948 | -9,575 |
EBIT | -8,883 | -10,510 |
Net Income | -8,823 | -6,879 |
Net Change In Cash | ||
Free Cash Flow | -6,334 | -6,350 |
Cash | 3,562 | 5,241 |
Basic Shares | 23,977 | 22,290 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $2,308 | $ | $ | $15,182 |
Gross Profit | 2,308 | 15,182 | ||
EBITDA | -26,766 | -22,277 | -23,514 | -5,112 |
EBIT | -28,635 | -24,146 | -25,384 | -6,377 |
Net Income | -26,778 | -20,465 | -24,647 | -8,421 |
Net Change In Cash | 2,308 | 15,182 | ||
Free Cash Flow | -9,581 | -15,156 | -22,761 | -9,110 |
Cash | 1,657 | 5,241 | 7,361 | 27,586 |
Basic Shares | 18,428 | 13,246 | 117,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2021-03-31 | -$0.006 |
2020-12-31 | -$0.006 |
2020-09-30 | -$0.02 |
2020-06-30 | -$0.02 |
